8 In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion

9 Immunity and immunopathology to respiratory syncytial virus. The mouse model

10 Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection

11 Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection

12 Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice

13 Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived

14 Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus

15 Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies

16 Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35, after oral consumption

17 A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice

18 Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

19 The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection

20 Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice

21 Antiviral properties of extract of Opuntia streptacantha

22 Recognition of respiratory syncytial virus fusion protein by mouse cytotoxic T cell clones and a human cytotoxic T cell line

23 Esculetin from Fraxinus rhynchophylla attenuates atopic skin inflammation by inhibiting the expression of inflammatory cytokines

24 Respiratory syncytial virus infection in anti-mu-treated mice

25 Cytotoxic T cell activity against the 22-kDa protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication

26 CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells

27 Is the BCG vaccine safe for undernourished individuals?

28 Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse

29 Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus

30 Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen

31 'Self' tolerance in a parent-->F1 radiation chimera

32 The uPAR System as a Potential Therapeutic Target in the Diseased Eye

33 Present and future therapeutic strategies for melioidosis and glanders

34 Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum

35 Humanised monoclonal antibody to respiratory syncytial virus

36 Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins

37 Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells

38 Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

39 A Saccharomyces cerevisiae mutant with increased virulence

40 Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani

41 Bilateral Effect of the Unilateral Corneal Nerve Cut on Both Ocular Surface and Lacrimal Gland

42 Cow and Human Milk-Derived Exosomes Ameliorate Colitis in DSS Murine Model

43 Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection

44 Vasoactive Intestinal Peptide Promotes Corneal Allograft Survival

45 Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes

46 Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice

47 The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation

48 Interaction of trichohyalin with intermediate filaments: three immunologically defined stages of trichohyalin maturation

49 In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin

50 A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells

51 Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis

52 Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate

53 Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition

54 In vitro and in vivo activities of anti-influenza virus compound T-705

55 Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential

56 IL-10 mediates susceptibility to Leishmania donovani infection

57 A comparative study of polyclonal and monoclonal antibodies for immunocytochemical localization of cytosolic aspartate aminotransferase in rat liver

58 BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells

59 Kinetics of mast cells, eosinophils and phospholipase B activity in the spontaneous-cure response of two strains of mice (rapid and slow responder) to the cestode Hymenolepis nana

60 Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice

61 Morphogenesis of ductal networks in the mouse prostate

62 A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

Keyword Connections

Journals

Research Groups

Bibliographies